Alnylam completes follow-on

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), Cambridge, Mass. Business: Infectious, Endocrine/Metabolic, Cancer Date completed: 1/15/13 Type: Follow-on Raised: $185.2 million Shares: 9.2 million Price:...